Sabrina Gaan
Optometrist · Medfield, MANPI 1548492705
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $57,197 of the $66,034 with a category attached, or 86.6%. Lumenis BE Inc accounts for 88.6% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $29,279, more than ten times the $49 reported in 2019. Among optometrist clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $507.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$58K
- Coopervision Inc.$3K
- Tarsus Pharmaceuticals, Inc.$2K
- Alcon$639
- Johnson & Johnson Vision Care, Inc.$615
- Glaukos Corporation$540
- plus $993 from 8 others
Across 2 payments — averaging $125.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tarsus Pharmaceuticals, Inc.$250
What the payments were for
- Consulting fees$1,3002%
- Speaking & faculty fees$5,7609%
- Travel & lodging$1,7773%
- Food & beverage$57,19787%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 4 | $58,496 |
| Coopervision Inc. | 22 | $3,237 |
| Tarsus Pharmaceuticals, Inc. | 22 | $1,514 |
| Alcon | 14 | $639 |
| Johnson & Johnson Vision Care, Inc. | 19 | $615 |
| Glaukos Corporation | 6 | $540 |
| Dompe US, Inc. | 11 | $300 |
| Bausch & Lomb Americas Inc. | 7 | $226 |
| Biotissue Holdings Inc. | 6 | $188 |
| Sun Pharmaceutical Industries Inc. | 13 | $176 |
| Oyster Point Pharma, Inc. | 2 | $41 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $34 |
| LKC Technologies, Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- optilight$58,496
- Biofinity Contact Lens$1,789
- MiSight Contact Lens$500
- ILUX$147
- Acuvue$143
- Precision 1$142
- Onefit Contact Lens$117
- KXL System$111
- Photrexa$111
How this compares
$66,034 in reported general payments places this provider in the 95th percentile of 1,084 optometrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 28 | $245 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Medfield
- Donald KorbBoston$373K
- Jaclyn GarlichBoston$162K
- Jessica CrookerScituate$99K
- Micaela CrowleyWestminster$88K
- Kristen BrownBoston$87K
- Timothy BossieBoston$75K
- Blair O'ReillyDedham$43K
- John MagalhaesN Dartmouth$40K
- Anita GulmiriBrookline$28K
- Lawerence BaitchWorcester$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.